Recombinant human growth hormone might become a great healing alternative for adults with acquired HGH deficiency. Recent research indicates that many of the metabolic and psychosomatic abnormalities connected with HGH deficiency can be reversed with human growth hormone therapy, even at low doses which are not connected with negative side effects.

With Hgh therapy one's body undergoes compositional changes. Lean mass is developed and fat masses become denser. The increase in lean mass is associated with an increase is muscle mass and function as well as an increased protein mixture. After six months of human growth hormone therapy one can expect a decrease in total body fat. Fat loss is most significant in trunk and visceral areas as oppose to the extremities and neck which suggests a reversal of the redistribution of fat resultant from HGH deficit and the associated cardiovascular risks.

Lipids may be helped by treating the patient with HGH. There is research proving that brief courses of human growth hormone helped reduce LDL cholesterol and this was associated with additional mRNA found in the liver's LDL receptor. One potential benefit of this association has not so far been studied with more extensive clinical trials. It must be said, however, that startling changes in serum lipid ratings is not always associated with administering HGH.

It has been discovered that body composition, bone density, lipid metabolism, cardiovascular function and emotional health can be helped through the use of Testosterone replacement. There are still important issues to be researched, including determining a precise clinical definition of partial vs. complete HGH deficiency and choosing which tests work best to determine this. It is also unclear if some of the positive effects found in experiments reflected HGH therapy through drugs rather than through the replacement therapy.

However it is possible to achieve success and the desired outcome with smaller doses. Future studies will eventually determine the safety and long-term effects of HGH therapy. The recommended dosage will have to take into account the cardiovascular morbidity and mortality rates.

Even though human growth hormone levels reduce with age, it has not been proven that trying to keep the amounts that are in young people is preferred. It is believable that age-related hormonal changes may be useful markers of physiological aging. However, this has not been shown experimentally for humans. Although hormone-replacement exams have shown some constructive results, it is clear that negative side effects can also take place in the form of risks for cancer, cardiovascular disease, and behavior changes.